{
    "clinical_study": {
        "@rank": "68842", 
        "arm_group": [
            {
                "arm_group_label": "Roux en Y Gastric Bypass", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants will be those already scheduled to undergo Roux en Y Gastric Bypass Surgery"
            }, 
            {
                "arm_group_label": "Gut hormone infusion (high dose)", 
                "arm_group_type": "Experimental", 
                "description": "Infusion of three gut hormones - GLP-1, PYY and oxyntomodulin subcutaneously."
            }, 
            {
                "arm_group_label": "Gut hormone infusion (low dose)", 
                "arm_group_type": "Experimental", 
                "description": "Infusion of three gut hormones - GLP-1, PYY and oxyntomodulin subcutaneously."
            }, 
            {
                "arm_group_label": "Placebo infusion", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Saline infusion given subcutaneously"
            }, 
            {
                "arm_group_label": "Very low calorie diet", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants will be asked to follow a very low calorie diet for 4 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess whether the changes in gut hormones seen following\n      Roux en Y Gastric Bypass surgery are responsible for some of the beneficial effects seen\n      post-operatively."
        }, 
        "brief_title": "Gut Hormones and Roux en Y Gastric Bypass", 
        "completion_date": {
            "#text": "October 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obesity", 
            "Type 2 Diabetes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 2", 
                "Obesity"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Body mass index \u226450 kg/m2.\n\n          -  Eligible for bariatric surgery under the NHS.\n\n          -  Diagnosed with impaired glucose regulation or type 2 diabetes, according to WHO 2011\n             criteria. For the dose finding study, non-diabetics can also be recruited.\n\n          -  Those with diabetes should be stable and well controlled with either diet or one oral\n             hypoglycaemic agent.\n\n          -  HbA1c \u22648.0% or 64 mmol/mol.\n\n        Exclusion Criteria:\n\n          -  History of any medical, psychological or other condition, or use of any medications,\n             including over-the-counter products, which, in the opinion of the investigators,\n             would either interfere with the study or potentially cause harm to the volunteer.\n\n          -  Without access at home to a telephone or other factor likely to interfere with\n             ability to participate reliably in the study.\n\n          -  Pregnancy or breastfeeding.\n\n          -  Smokers.\n\n          -  Unable to maintain adequate contraception for the duration of the study and for one\n             month afterwards.\n\n          -  History of hypersensitivity to any of the components of the subcutaneous infusions.\n\n          -  Donated blood during the preceding 3 months or intention to do so before the end of\n             the study.\n\n          -  Insulin treatment.\n\n          -  Uncontrolled hypertension.\n\n          -  Any other co-morbidity that would compromise the validity of the study or the safety\n             of the participant such as heart failure, clinically apparent cardiovascular disease.\n\n          -  Unable to give informed consent.\n\n          -  Previous bariatric surgery.\n\n          -  Unable to undergo fMRI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "136", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01945840", 
            "org_study_id": "MR/K02115X/1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Roux en Y Gastric Bypass", 
                "intervention_name": "Roux en Y Gastric Bypass Surgery", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Gut hormone infusion (high dose)", 
                "intervention_name": "Gut hormone infusion (high dose)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Gut hormone infusion (low dose)", 
                "intervention_name": "Gut hormone infusion (low dose)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Placebo infusion", 
                "intervention_name": "Placebo infusion", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Very low calorie diet", 
                "intervention_name": "Very low calorie diet", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom", 
                    "state": "Greater London"
                }, 
                "name": "NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital"
            }, 
            "investigator": {
                "last_name": "Stephen R Bloom, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "5", 
        "official_title": "Do Gut Hormones Mediate the Beneficial Effects of Roux-en-Y Bypass?", 
        "overall_contact": {
            "email": "t.tan@imperial.ac.uk", 
            "last_name": "Tricia Tan, MBChB MRCP"
        }, 
        "overall_official": {
            "affiliation": "Imperial College London", 
            "last_name": "Stephen R Bloom, FRS FRCP MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Research Ethics Committee", 
                "United Kingdom: National Institute for Health Research"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Weight loss as measured at baseline compared to 4 weeks after infusion or diet", 
            "measure": "Weight loss", 
            "safety_issue": "No", 
            "time_frame": "Baseline - 4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01945840"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "As assessed by change in fructosamine and HbA1c levels", 
            "measure": "Glycaemia", 
            "safety_issue": "No", 
            "time_frame": "Baseline - 4 weeks"
        }, 
        "source": "Imperial College London", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Imperial College London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}